Agenus is developing combination therapy for MSS cancers and seeking regulatory pathways in the US and Europe.
1 report, 1 independent
Updated Jun 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Agenus is developing combination therapy for MSS cancers and seeking regulatory pathways in the US and Europe.